{"id":50056,"date":"2022-10-25T19:01:52","date_gmt":"2022-10-25T17:01:52","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-long-read-sequencing-market-report-2022-potential-applications-in-clinical-sequencing-and-analysis-present-opportunities-researchandmarkets-com\/"},"modified":"2022-10-25T19:01:52","modified_gmt":"2022-10-25T17:01:52","slug":"global-long-read-sequencing-market-report-2022-potential-applications-in-clinical-sequencing-and-analysis-present-opportunities-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-long-read-sequencing-market-report-2022-potential-applications-in-clinical-sequencing-and-analysis-present-opportunities-researchandmarkets-com\/","title":{"rendered":"Global Long Read Sequencing Market Report 2022: Potential Applications In Clinical Sequencing And Analysis Present Opportunities – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Long Read Sequencing Market Size, Share & Trends Analysis Report by Technology (SMRT Sequencing), by Product, by Application, by Workflow, by End Use, Region and Segment Forecasts, 2022-2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global long read sequencing market size is expected to reach USD 4.53 billion by 2030, registering a CAGR of 14.74%, according to this report. Since the sequencing method has shown to be of utmost importance in modifying pharmaceuticals, there is also a cumulative market value for the expanding knowledge of long read sequencing. An increase in the adoption of these technologies for the analysis of structural variants is expected to drive the market throughout the forecast period.\n<\/p>\n

\nCurrently, a lot of research is being conducted which is forecast to give manufacturers a slight advantage as they develop new and advanced elongated read sequencing, as well as to open up a lot of other prospects in the long read sequencing market. Furthermore, owing to the ongoing COVID-19 pandemic, key players are working with public health laboratories and researchers around the world to support the current COVID-19 pandemic by rapid sequencing of the novel coronavirus SARS-CoV-2.\n<\/p>\n

\nCompanies are also involved in the development of workflows to characterize a wide range of pathogens in a sample. Recently, Oxford Nanopore Technologies developed LamPORE-a scalable, low-cost, rapid assay for the detection of SARS-CoV-2. A rise in the prevalence of genetic disorders combined with an increase in top manufacturers’ R&D expenditures in long-read sequencing technology is projected to greatly advance the industry. The long read technique is mostly used to study genetic disorders for which disease loci are either well-known or strongly suspected.\n<\/p>\n

\nIn addition, the limitations of clinical disease research based on next-generation sequencing could be partially overcome by these technologies. Since longer reads from a single DNA molecule are used, long-read sequencing methods have a distinct advantage over other technology. Another driver of market expansion is the rising acceptance of contemporary methods for medical diagnosis. The portability and real-time speed of LRS technology are further factors contributing to its rising demand.\n<\/p>\n

\nIt is additionally utilized to create a precise reference map of the chromosome centromere. In addition, numerous biotech firms are creating cutting-edge technologies that combine a fresh approach to library preparation with tools for genomic analysis. Accordingly, a number of researches show that LRS technology is quite useful for identifying novel harmful mutations in human disorders with unidentified genetic origins. This offers a wealth of potential for researchers to use whole-genome sequencing (WGS) technology to develop medical genetics.\n<\/p>\n

\nMarket Dynamics<\/strong>\n<\/p>\n

\nMarket Drivers\n<\/p>\n